Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer

International Journal of Clinical Oncology

Volumn 11, Issue 4, 2006, Pages 314-319

  Kobayashi, Masashi ^a   Matsui, Kaoru ^a   Hirashima, Tomonori ^a   Nitta, Takashi ^a   Sasada, Shinji ^a   Tada, Takuhito ^a,b   Minakuchi, Kazuo ^a   Furukawa, Mitsugi ^a,c   Ogata, Yoshitaka ^a,c   Kawase, Ichiro ^a,c  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiotherapy; Cisplatin; Non small cell lung cancer; Vinorelbine

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIEMETIC AGENT; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CREATININE; DEXAMETHASONE; NAVELBINE; SEROTONIN; SODIUM;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE CALCULATION; DRUG CYTOTOXICITY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; ESOPHAGITIS; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; HYPONATREMIA; INFECTION; LEUKOCYTE COUNT; LUNG NON SMALL CELL CANCER; MALE; MAXIMUM TOLERATED DOSE; NAUSEA; NEUTROPHIL COUNT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PHASE 1 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; SODIUM BLOOD LEVEL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIATION-SENSITIZING AGENTS; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 33748096754     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0574-5     Document Type: Article

References (33)

1. D Schottenfeld 2000 Etiology and epidemiology of lung cancer HI Pass JB Mitchell DH Johnson AT Turrisi JD Minna Lung cancer: principles and practice, second edn Lippincott Williams & Wilkins Philadelphia 367 88
2. DG Pfister DH Johnson CG Azzoli 2004 American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 330 353
3. AJ Wozniak JJ Crowley SP Balcerzak 1998 Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study J Clin Oncol 16 2459 2465
4. T Le Chevalier D Brisgand JY Douillard 1994 Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients J Clin Oncol 12 360 367
5. K Kelly J Crowley PA Bunn Jr 2001 Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial J Clin Oncol 19 3210 3218
6. GV Scagliotti F De Marinis M Rinaldi 2002 Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer J Clin Oncol 20 4285 4291
7. Kubota K, Nishiwaki Y, Ohashi Y et al. (2004) The four-arm cooperative study (FACS) for advanced non-small-cell lung cancer (NSCLC). J Clin Oncol 22 (Suppl):(abstract 7006)
8. EE Vokes RR Weichselbaum 1990 Concomitant chemoraditherapy: rationale and clinical experience in patients with solid tumors J Clin Oncol 8 911 934
9. IF Tannock 1996 Treatment of cancer with radiation and drugs J Clin Oncol 14 3156 3174
10. Y Nishimura 2004 Rationale for chemoradiotherapy Int J Clin Oncol 9 414 420
11. L Dewit 1987 Combined treatment of radiation and cis- diamminedichloroplatinum (II): a review of experimental and clinical data Int J Radiat Oncol Biol Phys 13 403 426
12. C Schaake-Koning W van den Bogaert O Dalesio 1992 Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 524 530
13. MP Edelstein LA Wolfe III DS Duch 1996 Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small-cell lung cancer Semin Oncol 23 Suppl 41 47
14. K Fukuoka H Arioka Y Iwamoto 2001 Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells Lung Cancer 34 451 460
15. K Fukuoka H Arioka Y Iwamoto 2002 Mechanism of vinorelbine-induced radiosensitization of human small cell lung cancer cells Cancer Chemother Pharmacol 49 385 390
16. Available at http://ctep.info.nih.gov/reporting/ctc.html
17. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216
18. EL Kaplan P Meier 1958 Nonparametric estimation for incomplete observations J Am Stat Assoc 53 457 481
19. RO Dillman SL Seagren KJ Propert 1990 A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 940 945
20. RO Dillman J Herndon SL Seagren 1996 Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial J Natl Cancer Inst 88 1210 1215
21. T Le Chevalier R Arriagada E Quoix 1991 Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 417 423
22. T Le Chevalier R Arriagada M Tarayre 1992 Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma J Natl Cancer Inst 84 58
23. WT Sause C Scott S Taylor 1995 Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer J Natl Cancer Inst 87 198 205
24. W Sause P Kolesar SIV Taylor 2000 Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 358 364
25. Non-small Cell Lung Cancer Collaborative Group 1995 Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials BMJ 311 899 909
26. RS Pritchard SP Anthony 1996 Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis Ann Intern Med 125 723 729 Erratum in: (1997) Ann Intern Med 126:670
27. K Furuse M Fukuoka M Kawahara 1999 Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 2692 2699
28. WJ Curran CB Scott CJ Langer 2003 Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410 Proc Am Soc Clin Oncol 22 621 abstract 2499
29. P Zatloukal L Petruzelka M Zemanova 2004 Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study Lung Cancer 46 87 98
30. H Choy WJ Curran Jr CB Scott 2002 Preliminary report of locally advanced multimodality protocol (LAMP): ACR 427: a randomized phase II study of three chemo-radiation regimens with paclitaxel, carboplatin, and thoracic radiation (TRT) for patients with locally advanced non small cell lung cancer (LA-NSCLC) Proc Am Soc Clin Oncol 21 291 abstract 1160
31. GA Masters DJ Haraf PC Hoffman 1998 Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies J Clin Oncol 16 2157 2163
32. EE Vokes JE Herndon II J Crawford 2002 Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: Cancer and Leukemia Group B study 9431 J Clin Oncol 20 4191 4198
33. I Sekine K Noda F Oshita 2004 Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer Cancer Sci 95 691 695